|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004083,
umls-concept:C0017262,
umls-concept:C0019829,
umls-concept:C0054946,
umls-concept:C0085133,
umls-concept:C0185117,
umls-concept:C0205210,
umls-concept:C0439858,
umls-concept:C0443177,
umls-concept:C0449450,
umls-concept:C1274040,
umls-concept:C1417326,
umls-concept:C1706319,
umls-concept:C2348519,
umls-concept:C2911684
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2002-2-28
|
|
pubmed:abstractText |
CD20 can be expressed in Hodgkin and Reed-Sternberg (HRS) cells of classical Hodgkin's disease (HD), but its clinical significance remains controversial. Therefore, we correlated CD20 expression with presenting features and clinical outcome of untreated patients with classical HD.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:AngelopoulouMaria KMK,
pubmed-author:BonadonnaGianniG,
pubmed-author:BonfanteValeriaV,
pubmed-author:CabanillasFernandoF,
pubmed-author:ChilosiMarcoM,
pubmed-author:GianniAlessandro MAM,
pubmed-author:GiardiniRobertoR,
pubmed-author:HerlingMarcoM,
pubmed-author:KittasChristosC,
pubmed-author:McLaughlinPeterP,
pubmed-author:MedeirosL JeffreyLJ,
pubmed-author:MesinaOfeliaO,
pubmed-author:NadaliGian-PaoloGP,
pubmed-author:PangalisGerassimos AGA,
pubmed-author:PizzoloGiovanniG,
pubmed-author:RassidakisGeorge ZGZ,
pubmed-author:RodriguezM AlmaMA,
pubmed-author:RomagueraJorgeJ,
pubmed-author:SarrisAndreas HAH,
pubmed-author:VassilakopoulosTheodoros PTP,
pubmed-author:VivianiSimonettaS
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1278-87
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:11870170-Adolescent,
pubmed-meshheading:11870170-Adult,
pubmed-meshheading:11870170-Aged,
pubmed-meshheading:11870170-Aged, 80 and over,
pubmed-meshheading:11870170-Antigens, CD20,
pubmed-meshheading:11870170-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11870170-Bleomycin,
pubmed-meshheading:11870170-Child,
pubmed-meshheading:11870170-Combined Modality Therapy,
pubmed-meshheading:11870170-Dacarbazine,
pubmed-meshheading:11870170-Doxorubicin,
pubmed-meshheading:11870170-Female,
pubmed-meshheading:11870170-Hodgkin Disease,
pubmed-meshheading:11870170-Humans,
pubmed-meshheading:11870170-Immunohistochemistry,
pubmed-meshheading:11870170-Male,
pubmed-meshheading:11870170-Middle Aged,
pubmed-meshheading:11870170-Neoplasm Staging,
pubmed-meshheading:11870170-Prednisone,
pubmed-meshheading:11870170-Reed-Sternberg Cells,
pubmed-meshheading:11870170-Survival Rate,
pubmed-meshheading:11870170-Vinblastine
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome.
|
|
pubmed:affiliation |
Department of Lymphoma-Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
|
|
pubmed:publicationType |
Journal Article
|
